BGLC vs ON · rev $9.5M vs P/E 36, rev $3.12B
BioNexus Gene Lab Corp Common stock (BGLC) versus ON Semiconductor Corporation (ON) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
ON Semiconductor Corporation (ON) is a semiconductors company listed on US.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
Latest reported ON revenue for 2026-07-03 was $3.12B. Net income was $193.4M. ON currently screens at market cap $21.90B and trailing P/E 36.4.
BGLC currently screens at market cap $6.1M. ON currently screens at market cap $21.90B and trailing P/E 36.4.
Not investment advice. Open the BGLC and ON stock pages for the full models.
Not investment advice.